BIOBANX INVENTORY

A Bio Repository for the Life Sciences

Global Bio specimen repository

Over the past two decades, Boca Biolistics has been building one of the largest, multi-national, commercial biobanks. We target multiple disease states,  including infectious, tropical, cardiovascular, and gastrointestinal diseases as well as neuro-degenerative disorders but with a sharp focus on Oncology.   Our library of over 500,000 data rich human biological specimens is available to our research partners quickly through our proprietary ERP.  Our specialized procurement department works diligently to add relevant specimens to this inventory, daily.  Our channels for procuring these specimens spans 5 continents and was developed over the past two decade.  Our CRS department provides the capability to quickly assess and initiate prospective collections for specimens that will meet the needs of our researchers pipeline development programs.  All of these capabilities, combines with our CAP accredited reference lab makes Boca Biolistics a unique partner for diagnostic and pharmaceutical research.  

 

Featured Inventory

Information on COVID-19 samples can be found here.

Over 750 unique acute/convalescent COVID-19 confirmed donors
Matched sets of saliva, swabs, plasma, serum, whole blood available
Worldwide populations including United States, South America, Africa, and Europe


BBL now offers COVID-19+ remnant serum specimens
Specimens confirmed positive by NP swab testing on Cepheid GeneXpert
Save now on a flat sample rate of $100/sample


Inventory consists of 3000+ specimens available in VTM, Saline, Aptima swabs, eSwab, and Liquid Amines.
EUA approved assays include Perkin Elmer, Hologic Panther/Panther Fusion, Abbott M2000, Cepheid GeneXpert, and many more
20% off negative swab specimens for a limited time. Exclusions apply. Discount does not apply to panels or positive specimens.


Limited supplies available for Pre-December 2019 Normal Healthy plasma/serum.
Matched sets of SARS-CoV-2 NAT/Ab confirmed negative Saliva, NP, Plasma, and serum available.
Bulk Plasma CPDA & Serum stocks available.
BBL SARS-CoV-2 Ab flash sale. $450 per panel until October 15th


Search our entire inventory

Once you have found what you're looking for, contact us with your request and our team will be with you shortly.



Sample Type
Matrix Type

Sample Subtype :
Acute Leptospira
Matrix Subtype :
Plasma, Plasma Na Citrate
Available Clinical Data:
Tropical Disease Other Signs and Symptoms, Tropical Disease Signs and Symptoms
Available Tests:
HAV RT-PCR, UltraQual 1000 2x

Sample Subtype :
aHBs Negative Donor
Matrix Subtype :
Plasma, Serum

Sample Subtype :
Albumin
Matrix Subtype :
Plasma, Serum, Amniotic Fluid
Available Clinical Data:
Date of Birth, Lipemia (laboratory evidence), Reported Age, Elevated albumin (Alb) (laboratory evidence), Date of Draw, Ethnicity, Subject is 18 years of age or older at the time of enrollment and blood draw, Alcoholic cirrhosis (clinical diagnosis and/or laboratory evidence), Date of Consent, Time of Draw, Date of Diagnosis, Country of Origin, Elevated alanine amino transferase (ALT) (laboratory evidence), City of Origin, Gender, Subject receiving treatment, Date of onset of first symptoms
Available Tests:
Triglycerides, HDL, Albumin, Cholesterol

Sample Subtype :
Alcoholic Cirrhosis
Matrix Subtype :
Plasma, Serum
Available Clinical Data:
Date of Birth, Lipemia (laboratory evidence), Reported Age, Elevated albumin (Alb) (laboratory evidence), Date of Draw, Ethnicity, Subject is 18 years of age or older at the time of enrollment and blood draw, Alcoholic cirrhosis (clinical diagnosis and/or laboratory evidence), Date of Consent, Time of Draw, Date of Diagnosis, Country of Origin, Elevated alanine amino transferase (ALT) (laboratory evidence), City of Origin, Gender, Subject receiving treatment
Available Tests:
NT-Pro BNP

Sample Subtype :
ALD
Matrix Subtype :
Plasma, Plasma EDTA K3
Available Clinical Data:
Date of Birth, Fibrosis Score (Choose One), Date of Draw, Ethnicity, Periportal Necroinflammatory Score (Choose one), Abbott Architect Anti HCV Result, Portal Inflammation Score (Choose one), Date sample frozen at -20 C or colder, Is the most recent liver biopsy result available?, Gender, Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Scoring System: Bridging and Confluent Necrosis Score (Choose One), Sample Storage Temperature
Available Tests:
Total Protein, Total Bilirubin, Abbott Anti-HCV, Abbott HIV Ag/AB Combo, AST, Abbott HBsAg Qualitative, ALT, Abbott Syphilis TP

Sample Subtype :
ALP
Matrix Subtype :
Serum

Sample Subtype :
Cockroach, Mold
Matrix Subtype :
Serum
Available Tests:
Immulite Allergy IgE

Sample Subtype :
ALT
Matrix Subtype :
Plasma, Serum
Available Clinical Data:
Date of Birth, Lipemia (laboratory evidence), Reported Age, Elevated albumin (Alb) (laboratory evidence), Date of Draw, Ethnicity, Subject is 18 years of age or older at the time of enrollment and blood draw, Alcoholic cirrhosis (clinical diagnosis and/or laboratory evidence), Date of Consent, Time of Draw, Date of Diagnosis, Country of Origin, Elevated alanine amino transferase (ALT) (laboratory evidence), City of Origin, Gender, Subject receiving treatment, Current Medications or Treatments 1, Medication Start Date, Date of onset of first symptoms
Available Tests:
ALT

Sample Subtype :
ANA
Matrix Subtype :
Plasma, Serum, Plasma EDTA K3
Available Clinical Data:
Date of Birth, Reported Age, Date of Draw, Ethnicity, Rheumatology Condition, Time of Draw, Date of Diagnosis, Country of Origin, City of Origin, Gender
Available Tests:
Triglycerides, Rheumatoid Factor, Total Protein, ANA IgG, Total Bilirubin, Immunoglobulin G, NT-Pro BNP, Chloride (Cl), Abbott Anti-HCV, Potassium (K), Anti-Nuclear Antibodies (ANA), IgG by ELISA, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Albumin, Cholesterol, Direct Bilirubin, Phosphorus, Calcium, ANA, IgG by IFA, ANA, Cyclic Citrullinated Peptide (CCP) Antibody, IgG, Sodium (NA)

Sample Subtype :
AST
Matrix Subtype :
Serum, Plasma EDTA K3
Available Tests:
Abbott Anti-HCV, Abbott HIV Ag/AB Combo, AST, Abbott HBsAg Qualitative

Sample Subtype :
Guillain-Barre
Matrix Subtype :
Plasma, Plasma EDTA K3

Sample Subtype :
Scl-70, RNP, Jo-1, ds-DNA, TG, SSB, SM, Autoimmune Hep., SSA, MPO
Matrix Subtype :
Plasma, Serum, Plasma EDTA K3
Available Clinical Data:
Date of Birth, Reported Age, Fibrosis Score (Choose One), Date of Draw, Ethnicity, Periportal Necroinflammatory Score (Choose one), Subject is 18 years of age or older at the time of enrollment and blood draw, Date of Consent, Abbott Architect Anti HCV Result, Time of Draw, Portal Inflammation Score (Choose one), Date sample frozen at -20 C or colder, City of Origin, Is the most recent liver biopsy result available?, Gender, Liver Biopsy Date Tested:, Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Current Medications or Treatments 1, Scoring System: Bridging and Confluent Necrosis Score (Choose One), Sample Storage Temperature
Available Tests:
dsDNA AB, SM AB, Thyroglobulin, Antineutrophil cytoplasmic antibodies, SSA AB, AST, SCL70 AB, ALT, SSB AB, JO1-IGG- AB, RNP AB

Sample Subtype :
Bilirubin-Total
Matrix Subtype :
Serum, Plasma EDTA K3

Sample Subtype :
Blood Donor
Matrix Subtype :
Plasma

Sample Subtype :
Blood Urea Nitrogen
Matrix Subtype :
Serum

Sample Subtype :
Cadaveric
Matrix Subtype :
Serum Non-SST, Plasma, Serum, Plasma EDTA K2, Serum SST, Plasma EDTA K3
Available Clinical Data:
Reported Age, Date of Draw, Date and Time of Draw, Ethnicity, Sample Hemolysis Level (Qualtex Color Comparator), Time Between Death and Blood Draw (Minutes), Time of Draw, Transfusion and/or Infusion of blood or colloids in excess of 2,000mL within 48 hours prior to collection of the blood specimen?, Country of Origin, Date sample frozen at -20 C or colder, Date and Time Sample Frozen at -20 C or Colder, If transfusion or infusion of blood or colloids is less than 2,000mL, how many mL?, Time of Death, Gender, Transfusion and/or Infusion of crystalloids in excess of 2,000mL within 1 hours prior to collection of the blood specimen?, Date of Death, Cause of Death, Time Frozen at -20 C or colder, If transfusion and/or infusion of crystalloids in less than 2,000mL, how many mL?, Date and Time of Death
Available Tests:
Genetic Systems HBsAg EIA 3.0, CMV Antibody IgG, Abbott Anti-HCV, HIV-1/HCV/HBV Ultrio Screen, Aptima Zika Virus Assay - Serum, Liaison CMV IgG, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Abbott Syphilis TP, HIV 1/2 ab, CMV Antibody IgM, Anti-HCV EIA: (Ortho HCV 3.0 EIA Test System), Aptima Zika Virus Assay - Plasma, Hepatitis B Virus Surface Antibody, COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, WNV-PCR: (Roche WNV-PCR), Abbott Anti-HBs (AUSAB)

Sample Subtype :
Calcium
Matrix Subtype :
Serum

Sample Subtype :
Cancer, Gastric Cancer, Uterine Cancer, Breast Cancer, Serosa Cancer, Intestine Cancer, Larynx Cancer, Testicular Cancer, Salivary Gland Cancer, Liver Cancer, Cervical Cancer, Lung Cancer, Kidney Cancer, Bladder Cancer, GEJ, Thyroid Cancer, Head and Neck Cancer, Bone Cancer, Colon Cancer, Abdominal Cancer, Rectal Cancer, Prostate Cancer, ICC, Non-Hodgkins Lymphoma, Cholangocarcinoma, Lymph Node, Pelvic Tumor, Stomach Cancer, CA 19-9, Gallbladder Cancer, Skin Cancer, Brain Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Endometrium Cancer, Melanoma, Penile Cancer, NSCLC
Matrix Subtype :
FFPE Tumor, Plasma, Serum, Plasma EDTA K2, Plasma cf-DNA, FFPE NAT, FFPE Metastasis, Slides, Plasma EDTA K3, Fresh Frozen Tissue, FFPE Tumor Curls
Available Clinical Data:
Donor HCV Status, Date of Birth, Time of Blood Collection, Presence of metastasis (M), Extent of spread to the lymph nodes (N), Reported Age, Donor HBV Status, Date of Tissue Procurement, Date of Surgery, Description of Diagnosis, Date and Time of Draw, Ethnicity, Extent of the tumor (T), Surgical Procedure, Patient Outcome Data, Minutes before fixation to Formalin, Donor HIV Status, Does the subject smoke?, Tumour Location, Tissue Size (cm), Stage of Cancer, Treatment History, Tumor Size (cm), Specimen Type, Pathology Report, Tumor Content (%), Distant metastasis location, Clinical Diagnosis (notes), Country of Origin, Time of tumour excision, Metastasis, Percent Necrosis, Histologic Type, Diagnosis (Oncology), Method of Verification, Gender, Grade of Cancer, Date of Blood Collection, Clinical Stage of Cancer, Current Medications or Treatments 1, Pathological Diagnosis, Date of Procurement
Available Tests:
Abbott Anti-HCV, Microsatellite Instable, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Tissue Quality Check, DIDO1, Abbott Syphilis TP, DID07, ACVR2A, SULF2, MRE11, BTBD7, CA19-9, RYR3, SEC31A, PD-L1 28-8 IHC

Sample Subtype :
Carbon Dioxide
Matrix Subtype :
Serum

Sample Subtype :
Cardiac
Matrix Subtype :
WB EDTA K2

Sample Subtype :
CARDIOLIPIN IgM, CARDIOLIPIN IgA
Matrix Subtype :
Serum

Sample Subtype :
CSF
Matrix Subtype :
CSF

Sample Subtype :
Chagas, Chagas Endemic
Matrix Subtype :
Saliva, Plasma, Serum, Whole Blood, Urine
Available Clinical Data:
Subject is 18 years of age or older at the time of enrollment and blood draw, Tropical Disease Other Signs and Symptoms, Pregnant?, Suspected Tropical Disease, Tropical Disease Signs and Symptoms, Date of onset of first symptoms
Available Tests:
Trypanosoma cruzi, IgG, Chagatest HAI, DiaSorin Zika IgM, Anti-T. cruzi EIA: (Ortho T. cruzi ELISA Test System), Abbott Anti-HCV, InBios Zika IgM Capture, DiaPro Zika Virus IgG, Aptima Zika Virus Assay - Serum, InBios Anti-Dengue IgM, InBios Anti-Dengue IgG, Abbott HIV Ag/AB Combo, DiaPro Anti-Chikungunya IgG, Abbott HBsAg Qualitative, InBios Chikungunya IgM, Abbott Syphilis TP, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Varicella-Zoster Virus Antibody, IgG, Trypanosoma cruzi, IgM, Toxoplasma gondii Antibody, IgG

Sample Subtype :
Acute Chikungunya, Chikungunya PL, Chikungunya
Matrix Subtype :
Saliva, WB EDTA K3, Plasma, Serum, Whole Blood, Urine, Plasma Na Citrate, Plasma EDTA K3
Available Clinical Data:
Date of Draw, Tropical Disease Signs and Symptoms, Date of onset of first symptoms
Available Tests:
DiaSorin Zika IgM, InBios Dengue NS-1, InBios WNV IgM, InBios Zika IgM Capture, DiaPro Zika Virus IgG, Aptima Zika Virus Assay - Serum, InBios Anti-Dengue IgM, InBios Anti-Dengue IgG, DiaPro Anti-Chikungunya IgG, EuroImmun Anti-Chikungunya Virus IgM, InBios Chikungunya IgG, InBios WNV IgG, InBios Chikungunya IgM, ZIKV Detect 2.0 IgM Capture ELISA, Aptima Zika Virus Assay - Plasma

Sample Subtype :
Chloride
Matrix Subtype :
Serum
Available Tests:
Chloride (Cl)

Sample Subtype :
Cholesterol
Matrix Subtype :
Serum

Sample Subtype :
CMV, CMV IgG
Matrix Subtype :
Plasma, Serum, Plasma EDTA K2, Plasma EDTA K3
Available Tests:
CMV PCR, Abbott Anti-HCV, CMV IgG, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, CMV Antibody IgM

Sample Subtype :
Cerebral Ischemia, Hydrocephalus
Matrix Subtype :
CSF

Sample Subtype :
Cord Blood
Matrix Subtype :
Aspirate
Available Clinical Data:
Date of Birth, Date of Draw, Time of Centrifugation, Ethnicity, Does the patient have diagnostic testing?, Subject is 18 years of age or older at the time of enrollment and blood draw, Date of Consent, Time of Draw, Country of Origin, City of Origin, Suspected Tropical Disease, Gender, If pregnant, which trimester?, Tropical Disease Signs and Symptoms, Date of onset of first symptoms, Patient Has Documentation For Yellow Fever Vaccination, Time Frozen at -20 C or colder

Sample Subtype :
COVID-19
Matrix Subtype :
Serum Non-SST, Saliva, Plasma, Serum, Whole Blood, Serum SST, Nasopharyngeal swabs, Spectrum DNA Saliva, OraSure Saliva, Plasma Na Citrate, DNA Genotek Saliva, Plasma EDTA K3, UTM
Available Clinical Data:
Date of Birth, Reported Age, Symptomology at the Time of Diagnosis, Date of Draw, Time of Centrifugation, Ethnicity, Location of the Worker's Health Center, Test Date (site reported results), Date of Consent, Pre-Existing Medical Conditions, Time of Draw, In the 14 days prior to illness onset, did the subject have any of the following exposures?, Country of Origin, City of Origin, Did the subject receive Mechanical Ventilation (MV) / Intubation?, Signs and Symptoms (Respiratory Infection), Gender, Was the subject hospitalized?, If pregnant, which trimester?, Date of hospitalization, Fever Temperature (F), Concomitant Medications (if reported), Is the subject a healthcare worker?, Date of onset of first symptoms, COVID-19 PCR Test Manufacturer, Time Frozen at -20 C or colder, Date of discharge from hospital?, Site reported laboratory results, Day(s) subject received mechanical ventilation (MV) / Intubation
Available Tests:
LIAISON SARS-CoV-2, Liaision SARS-CoV-2 Ab, EuroImmun COVID-19 IgG, Abbott Anti-HCV, GeneXpert SARS-CoV-2, EDI COVID-19 IgM, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, EuroImmun COVID-19 IgA, Architect SARS-CoV-2 IgG

Sample Subtype :
Creatinine
Matrix Subtype :
Serum

Sample Subtype :
Crohns Disease
Matrix Subtype :
Serum SST, Plasma EDTA K3
Available Clinical Data:
Date of FCP Result, If on medications, for how long? (days), Date of Birth, Ethnicity (hispanic specific), Reported Age, Date of Draw, Ethnicity, Prior Biologic Treatment History, Date of CRP result, Subject is 18 years of age or older at the time of enrollment and blood draw, What medication(s) is the subject currently taking?, Most recent Fecal Calprotectin (FCP) result, Date of Consent, Time of Draw, Date of Diagnosis, Gastroenterology Condition, Disease Status at time of sample collection, Clinical Symptom Score (CD: CDAI), Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Most recent C-reactive protein (CRP) result, Gender, Time Frozen at -20 C or colder, Is the subject currently on medications?

Sample Subtype :
Cryptococcus
Matrix Subtype :
Serum
Available Tests:
Cryptococcus Ag

Sample Subtype :
CMV
Matrix Subtype :
Plasma

Sample Subtype :
Acute Dengue, Symp. DENV Pregnant
Matrix Subtype :
WB EDTA K3, Plasma, Serum, Serum SST, Plasma EDTA K3
Available Clinical Data:
Date of Draw, Tropical Disease Other Signs and Symptoms, Infection Status, Subject has high fever and at least two tropical disease signs and symptoms, Tropical Disease Signs and Symptoms, Date of onset of first symptoms
Available Tests:
DiaSorin Zika IgM, InBios Dengue NS-1, HAV RT-PCR, UltraQual 1000 2x, InBios WNV IgM, EuroImmun Anti-Chikungunya Virus IgG, InBios Zika IgM Capture, DiaPro Zika Virus IgG, Aptima Zika Virus Assay - Serum, InBios Anti-Dengue IgM, InBios Anti-Dengue IgG, DiaPro Anti-Chikungunya IgG, EuroImmun Anti-Chikungunya Virus IgM, InBios Chikungunya IgM, DiaPro Anti-Chikungunya IgM, Aptima Zika Virus Assay - Plasma

Sample Subtype :
Dialysis
Matrix Subtype :
Plasma, Serum, Serum SST, Dialyzate Fluid, Urine, Plasma EDTA K3
Available Clinical Data:
Date and Time of Draw, Days subject undergoes dialysis, Creatine, How long (hours) is each Dialysis procedure?, Blood Counts, Date of first dialysis, Date and Time of Death
Available Tests:
NT-Pro BNP, Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Abbott Syphilis TP

Sample Subtype :
EBV IgG, EBV VCA IgG, EBV IgG., EBV
Matrix Subtype :
Plasma, Serum, Plasma EDTA K2, Plasma Na Citrate, Plasma EDTA K3
Available Tests:
Epstein-Barr Virus Ab to Early D Antigen, IgG, EBV by Quantitative PCR, Abbott Anti-HCV, Epstein-Barr virus Ab to Viral Capsid Antigen, IgM, CMV IgG, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, EBV VCA IgG, EBV by Qualitative PCR, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Epstein-Barr Virus Ab to Nuclear antigen, Igg

Sample Subtype :
End-stage Cirrhosis
Matrix Subtype :
Plasma EDTA K3
Available Clinical Data:
Date of Birth, Fibrosis Score (Choose One), Date of Draw, Ethnicity, Periportal Necroinflammatory Score (Choose one), Abbott Architect Anti HCV Result, Portal Inflammation Score (Choose one), Date sample frozen at -20 C or colder, Is the most recent liver biopsy result available?, Gender, Liver Biopsy Date Tested:, Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Scoring System: Bridging and Confluent Necrosis Score (Choose One), Sample Storage Temperature
Available Tests:
Total Protein, Total Bilirubin, Abbott Anti-HCV, Abbott HIV Ag/AB Combo, AST, Abbott HBsAg Qualitative, ALT, Abbott Syphilis TP

Sample Subtype :
EBV IgG, EBV VCA IGM
Matrix Subtype :
Plasma
Available Tests:
Epstein-Barr Virus Ab to Early D Antigen, IgG, Epstein-Barr virus Ab to Viral Capsid Antigen, IgM, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Epstein-Barr Virus Ab to Nuclear antigen, Igg

Sample Subtype :
Febrile
Matrix Subtype :
Serum, Plasma EDTA K3

Sample Subtype :
Ferritin
Matrix Subtype :
Serum
Available Tests:
Ferritin

Sample Subtype :
Norovirus Positive
Matrix Subtype :
Stool liquid
Available Tests:
NOROVIRUS G1/G2

Sample Subtype :
B12
Matrix Subtype :
Plasma Na Heparin, Plasma Lithium Heparin
Available Tests:
B12, ALT

Sample Subtype :
Gentamicin
Matrix Subtype :
Serum

Sample Subtype :
Glucose
Matrix Subtype :
Serum

Sample Subtype :
HAVPL, Acute HAV, HAV
Matrix Subtype :
Saliva, WB PAXgene RNA, Plasma, Serum, Plasma EDTA K2, Whole Blood, Urine, Plasma Na Citrate, Plasma EDTA K3, Plasma PPT EDTA K2
Available Clinical Data:
Date of Birth, Date of Draw, Time of Centrifugation, Ethnicity, Does the patient have diagnostic testing?, Subject is 18 years of age or older at the time of enrollment and blood draw, Date of Consent, Signs and Symptoms (Hepatitis A), Tropical Disease Other Signs and Symptoms, Time of Draw, Country of Origin, City of Origin, Suspected Tropical Disease, Gender, Tropical Disease Signs and Symptoms, Date of onset of first symptoms, Patient Has Documentation For Yellow Fever Vaccination, Time Frozen at -20 C or colder
Available Tests:
HAV RT-PCR, UltraQual 1000 2x, Architect Anti-HAV IgG, EBV by Qualitative PCR, Architect Anti-HAV IgM, Syphilis MHA-TP, COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, WNV-PCR: (Roche WNV-PCR)

Sample Subtype :
HBcAb
Matrix Subtype :
Serum

Sample Subtype :
HBeAG
Matrix Subtype :
Serum

Sample Subtype :
HBsAb
Matrix Subtype :
Plasma, Serum

Sample Subtype :
HBcIgM, HBcAb, Acute HBV, HBV, HBeAb, HBsAg
Matrix Subtype :
Serum Non-SST, Plasma, Serum, Plasma EDTA K2, Plasma CPDA, Serum SST, Plasma CPD, Plasma Na Citrate, Plasma EDTA K3, Human Cord Serum, Plasma PPT EDTA K2
Available Clinical Data:
HBV Genotype test performed?:, Date of Birth, Presence of metastasis (M), Extent of spread to the lymph nodes (N), Reported Age, Description of Diagnosis, Date of Draw, If yes, result: (HBV Genotype test performed), Ethnicity, Extent of the tumor (T), Signs and Symptoms (Hepatitis B), Subject is 18 years of age or older at the time of enrollment and blood draw, Tumour Location, Date of Consent, If yes, result: (Anti H Be test performed), Stage of Cancer, Date of Diagnosis, Time of Draw, If yes, date performed ( HBV Genotype test performed), Tumor Size (cm), Current HBV Medications (please check all types that apply):, Country of Origin, City of Origin, If yes, stage of biopsy (Biopsy performed), Biopsy performed?, Histologic Type, If yes, date performed (Biopsy performed), Method of Verification, Gender, Infection Status, Date of Blood Collection
Available Tests:
Quest HBV_Genotype, n/a, COBAS Ampliprep/TaqMan 48 HBV, v2.0, Abbott HBc IgM, Epstein-Barr Virus Ab to Early D Antigen, IgG, DiaSorin HBeAg, Immunoglobulin G, HBV Precore Mutations, HBV Mutations: Other, COBAS AmpliPrep/COBAS HCV Test v2.0. (Roche Molecular Systems Inc), HBV Precore (TAG) Mutations, Abbott Anti-HCV, Abbott HB Core, Epstein-Barr virus Ab to Viral Capsid Antigen, IgM, HBV BCP Mutations, Abbott HIV Ag/AB Combo, COBAS AmpliPrep HIV-1 Test, Abbott HBsAg Qualitative, Versant HBV bDNA 3.0, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Hepatitis B Virus Genotype by Sequencing, PRISM HBsAg, Quest Diagnostics HBV Genotyping LDT, Epstein-Barr Virus Ab to Nuclear antigen, Igg, DiaSorin Anti-HBe, COBAS AmpliPrep/COBAS TAQMAN HBV Test V2.0 (Roche Molecular Systems Inc.), HBV Polymerase Mutations, COBAS TaqMan HBV Test v2.0 (Roche Molecular Systems Inc.), TRUGENE HBV genotyping assay_Siemens Medical Solutions Diagnostics, COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, Abbott Anti-HBs (AUSAB)

Sample Subtype :
HCV GT 5, HCV GT 1B, HCV GT 2B, HCV GT 4A, HCV GT 3, HCV Ag, HCV GT 4, HCV GT 4C, HCV GT 3A, HCV IgM, Acute HCV, HCV GT 1A, HCV GT 6, HCV GT 4E, HCV, HCV GT 3B
Matrix Subtype :
Plasma ACD-A, Plasma, Serum, Plasma CPDA, Serum SST, Plasma CPD, Plasma EDTA K3
Available Clinical Data:
HBV Genotype test performed?:, Date of Birth, Date of Draw, If yes, result: (HBV Genotype test performed), Ethnicity, Sample Hemolysis Level (Qualtex Color Comparator), Subject is 18 years of age or older at the time of enrollment and blood draw, Date of Consent, If yes, result: (Anti H Be test performed), Date of Diagnosis, If yes, date performed ( HBV Genotype test performed), Country of Origin, City of Origin, Biopsy performed?, Gender, Infection Status, Date of onset of first symptoms
Available Tests:
INNO-LiPA HCV Genotype, n/a, COBAS Ampliprep/TaqMan 48 HBV, v2.0, Total Protein, Ortho HCV Version 3.0 ELISA Test System, Abbott HBc IgM, Total Bilirubin, DiaSorin HBeAg, Immunoglobulin G, Hepatitis C Viral RNA LiPA, HBV Mutations: Other, HCV_Genotype, COBAS AmpliPrep/COBAS HCV Test v2.0. (Roche Molecular Systems Inc), HBV Precore (TAG) Mutations, Abbott Anti-HCV, Abbott HB Core, Bayer VERSANT HCV RNA 3.0, COBAS AmpliPrep COBAS TaqMan HCV Test v2.0, HBV BCP Mutations, Abbott HIV Ag/AB Combo, COBAS AmpliPrep HIV-1 Test, Abbott HBsAg Qualitative, Hep C Virus Genotyping, Versant HCV RNA ASSAY (bDNA) 3.0, COBAS Ampliprep/TaqMan 48 HIV-1, v2.0, PRISM HBsAg, DiaSorin Anti-HBe, COBAS Ampliprep/TaqMan48 HCV, v2.0, COBAS AmpliPrep/COBAS TAQMAN HBV Test V2.0 (Roche Molecular Systems Inc.), eSensor HCVg Direct test, COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, Abbott Anti-HBs (AUSAB)

Sample Subtype :
IgM, Total Antibodies, HDV
Matrix Subtype :
Plasma, Serum
Available Tests:
Hepatitis Delta Virus Antibody

Sample Subtype :
Helicobacter pylori
Matrix Subtype :
Plasma, Plasma EDTA K2
Available Clinical Data:
Identity of Bacterial Infection

Sample Subtype :
HEV, HEV IgM, HEVAb
Matrix Subtype :
Plasma, Serum
Available Tests:
Hepatitis E Virus (HEV) Antibody, IgG, Hepatitis E Virus (HEV) Antibody, IgM

Sample Subtype :
HGV
Matrix Subtype :
Serum
Available Tests:
Hepatitis G Virus PCR

Sample Subtype :
HIV-2, HR HCV Preg, Adult High Risk, HR HCV, HR HIV Preg, HBV, High Risk, High Risk HIV-2, HCV
Matrix Subtype :
Plasma, Serum, Plasma EDTA K2, Plasma EDTA K3
Available Clinical Data:
Date of Birth, HCV Risk Factors, Fibrosis Score (Choose One), Date of Draw, Ethnicity, Periportal Necroinflammatory Score (Choose one), Sample Hemolysis Level (Qualtex Color Comparator), Date of Consent, Portal Inflammation Score (Choose one), Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Is the most recent liver biopsy result available?, Gender, If pregnant, which trimester?, Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Scoring System: Bridging and Confluent Necrosis Score (Choose One), Subject is at increased risk of HIV Infection. See below Table 1. Check one or more of the following risk factors. Present documentation when applicable, Sample Storage Temperature
Available Tests:
Ferritin, Rheumatoid Factor, Total Protein, Bio-Rad Geenius HIV 1/2 Supplemental Assay, TSH, Total Bilirubin, NT-Pro BNP, Insulin-Like Growth Factor (IGF-1), FSH, Zeptometrix HIV-1 p24 Antigen, Abbott Anti-HCV, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Liaison CMV IgG, Human Chorionic Gonadotropin (hCG), Luteinizing Hormone (LH), Abbott HIV Ag/AB Combo, LIAISON Mumps IgG, AST, Free T3, Abbott HBsAg Qualitative, Alkaline Phosphatase, ALT, Abbott Syphilis TP, PSA (Prostatic Specific Antigen), Direct Bilirubin, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Varicella-Zoster Virus Antibody, IgG, Progesterone II Gen, hGH, LIAISON Measles IgG, ANA, IgG by IFA, LIAISON Rubella IgG, Prolactin, Testosterone, Free T4, Free PSA (Prostatic Specific Antigen), Cyclic Citrullinated Peptide (CCP) Antibody, IgG

Sample Subtype :
HIV-G, HIV-O, HIV-2, HIV-1, HIV G/CRF 14, HIV, High Risk HIV-2, HIV-0
Matrix Subtype :
Serum Non-SST, WB EDTA K3, Plasma, Serum, WB EDTA K2, Plasma EDTA K2, Plasma CPDA, DBS (Finger Prick), Serum SST, WB Na Heparin, WB Greiner PPT, Plasma CPD, WB Serum, DBS (Venous), Plasma Na Citrate, Plasma Lithium Heparin, Plasma EDTA K3, Human Cord Serum
Available Clinical Data:
Date of Birth, If no has the subject been on previous antiretroviral medication?, Reported Age, Date DBS finger prick frozen at -20 C or colder, Test Manufacturer, Date of Draw, Time of Centrifugation, Ethnicity, Sample Hemolysis Level (Qualtex Color Comparator), Date of DBS venous, Combination HIV medicines, Date of HIV diagnosis, Subject is 18 years of age or older at the time of enrollment and blood draw, Date of DBS finger prick, Date of finger prick, Date of Consent, Fusion Inhibitors, Time of Draw, Date of Diagnosis, Integrase Inhibitors, Time of DBS finger prick, Pharmacokinetic Enhancers, Previous HIV Medications, Other (Medications), Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Time of DBS venous, Gender, Time of finger prick, If pregnant, which trimester?, Non-nucleoside Reverse Transcriptase Inhibitors (NRTIs), Protease Inhibitors (PIs), Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Time DBS finger prick frozen at -20 C or colder, Subject is at increased risk of HIV Infection. See below Table 1. Check one or more of the following risk factors. Present documentation when applicable, Time DBS venous frozen at -20 C or colder, Date DBS venous frozen at -20 C or colder, Time Frozen at -20 C or colder
Available Tests:
Genetic Systems HBsAg EIA 3.0, Versant HIV-1 RNA 3.0 (bDNA), n/a, Total Protein, Bio-Rad GEENIUS TEMPORARY CODE, HIV-2 Qual NAT, Bio-Rad Geenius HIV 1/2 Supplemental Assay, Total Bilirubin, COBAS AmpliPrep COBAS TaqMan HIV-1 Test_Roche Molecular Systems, Immunoglobulin G, Beta-hCG, Serum Qualitative, HBsAg by FDA Licensed test, COBAS AmpliPrep/COBAS HCV Test v2.0. (Roche Molecular Systems Inc), Zeptometrix HIV-1 p24 Antigen, InBios WNV IgM, Abbott Anti-HCV, Abbott HB Core, Liaison CMV IgG, HIV-1 Viral Load, Cobas TaqScreen West Nile Virus, HIV-2 RNA PCR NAT, Abbott HIV Ag/AB Combo, LIAISON Mumps IgG, COBAS AmpliPrep HIV-1 Test, Abbott HBsAg Qualitative, InBios WNV IgG, Abbott Syphilis TP, HIV-1 by Quantitative PCR, Bio-Rad Genie III HIV-1/HIV-2, COBAS Ampliprep/TaqMan 48 HIV-1, v2.0, PRISM HBsAg, LIAISON Measles IgG, HIV-2 Quant NAT, HIV-2 SuperCycle Assay, LIAISON Rubella IgG, HIV-2 RNA Viral Load, COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, WNV-PCR: (Roche WNV-PCR), Syphilis, Bio-Rad Genie II HIV-1/HIV-2

Sample Subtype :
Testosterone, 25 OH Vitamin D, TSH
Matrix Subtype :
Serum CAT, Saliva, Serum, Plasma EDTA K2, Plasma Lithium Heparin
Available Clinical Data:
Reported Age, Date of Draw, Ethnicity, Gender
Available Tests:
TSH, DiaSorin Zika IgM, Vitamin D-25, Testosterone

Sample Subtype :
Emergency Department, Hospital ICU Sepsis, Elevated WBC, Hospital Patient
Matrix Subtype :
Plasma, Serum, WB EDTA K2, BAL, Urine, Plasma Lithium Heparin, Stool liquid, Sputum
Available Tests:
Triglycerides, Sputum Quality, Clostridium difficile, Alkaline Phosphate, CMV PCR, TSH, BAL Quantitative Culture, Gram Stain, InBios Zika IgM Capture, Creatine, ALT, Sputum Culture, BUN, Procalcitonin

Sample Subtype :
HSV-1, HSV-2, HSV
Matrix Subtype :
Plasma, Serum, Plasma EDTA K2, M4 Media Swab
Available Clinical Data:
Donor Blood Type, Does the subject smoke?
Available Tests:
HSV Type 1 and/or 2 Ab, IgM by ELISA, HSV Type 2 Glycoprotein G-Specific Ab, IgG by CIA, Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Herpes Simplex Virus (HSV-1/HSV-2) Subtype, HSV Type 1 Glycoprotein G-Specific Ab, IgG by CIA

Sample Subtype :
HTLV, Anti-HTLV I/II
Matrix Subtype :
Plasma, Serum, Plasma EDTA K2, Serum SST, Plasma EDTA K3
Available Clinical Data:
Date of Birth, Subject has symptom / diagnosis of HAM / TSP, Signs and Symptoms (HAM / TSP), Date of Draw, Ethnicity, Signs and Symptoms (ATL), Subject is at increased risk for HTLV infection. Check one or more of the following risk factors., Stage of ATL, Time of Draw, Country of Origin, Gender, Time Frozen at -20 C or colder
Available Tests:
Abbott Anti-HCV, HTLV II IFA_State of California Department of Public Health, Human T-Lymphotropic Virus (HTLV) Types I/II Antibodies by ELISA, HTLV I IFA_State of California Department of Public Health, Abbott HIV Ag/AB Combo, COBAS AmpliPrep HIV-1 Test, Abbott HBsAg Qualitative, Versant HCV RNA ASSAY (bDNA) 3.0, HTLV I/II EIA_State of California Department of Public Health, Abbott Syphilis TP, HTLV-I/II Confirmation by Western Blot

Sample Subtype :
Hyperglobulinemia
Matrix Subtype :
Plasma EDTA K3
Available Tests:
Hyperglobulinemia IgM, Hyperglobulinemia IgG

Sample Subtype :
Increased Risk HIV-2, Increased Risk HCV, Inc. Risk HCV Ped., Increased Risk HIV-1
Matrix Subtype :
Serum Non-SST, Serum, Serum SST, Plasma EDTA K3
Available Clinical Data:
Date of Birth, HCV Risk Factors, Ethnicity (hispanic specific), Date of Draw, Time of Centrifugation, Ethnicity, Sample Hemolysis Level (Qualtex Color Comparator), Subject is 18 years of age or older at the time of enrollment and blood draw, Date of Consent, Time of Draw, Country of Origin, City of Origin, Subject is not at increased risk for HIV-1 infection., Gender, If pregnant, which trimester?, Subject is at increased risk of HIV Infection. See below Table 1. Check one or more of the following risk factors. Present documentation when applicable, Time Frozen at -20 C or colder
Available Tests:
Ferritin, TSH, Total Bilirubin, Insulin-Like Growth Factor (IGF-1), FSH, Abbott Anti-HCV, Liaison CMV IgG, Human Chorionic Gonadotropin (hCG), Luteinizing Hormone (LH), LIAISON Mumps IgG, AST, Free T3, Alkaline Phosphatase, ALT, Prostatic Specific Antigen, Total, PSA (Prostatic Specific Antigen), Direct Bilirubin, Progesterone II Gen, hGH, LIAISON Rubella IgG, Prolactin, Testosterone, Free T4, Free PSA (Prostatic Specific Antigen)

Sample Subtype :
Increased Risk HAV
Matrix Subtype :
Serum SST, Plasma EDTA K3
Available Clinical Data:
Date of Birth, Date of Draw, Ethnicity, Country of Origin, Gender, Subject is at increased risk of Hepatitis A. See below Table 1. Check one or more of the following risk factors. Present documentation when applicable:
Available Tests:
Architect Anti-HAV IgM

Sample Subtype :
Influenza
Matrix Subtype :
WB EDTA K3, Plasma, Serum, Whole Blood, Serum SST, Plasma EDTA K3
Available Clinical Data:
Date of Birth, Reported Age, Date of Draw, Signs and Symptoms (Flu), Ethnicity, Date of Diagnosis, Did the subject receive a flu vaccine for this season?, City of Origin, Gender, Fever Temperature (F), Date of onset of first symptoms
Available Tests:
Bordetella pertussis Antibody, IgG by ELISA, PolioVirus Antibody Type 3, Coxsackie B Virus Antibody Type 3, Influenza A Virus Antibody IgM, Coxsackie B Virus Antibody Type 6, Mycoplasma Pneumoniae Antibody IgM, Echovirus Antibody Type 7, Adenovirus Antibody, Serum, Influenza B Virus Antibody IgM, Echovirus Antibody Type 11, Alere i Influenza A & B, Abbott Anti-HCV, Echovirus Antibody Type 6, Echovirus Antibody Type 30, Mycoplasma Pneumoniae Antibody IgG, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Coxsackie A9 Virus Antibodies, Abbott Syphilis TP, Influenza A Virus Antibody IgG, Influenza B Virus Antibody IgG, Coxsackie B Virus Antibody Type 5, Coxsackie B Virus Antibody Type 1, PolioVirus Antibody Type 1, Echovirus Antibody Type 9, Coxsackie B Virus Antibody Type 2, Coxsackie B Virus Antibody Type 4

Sample Subtype :
INR
Matrix Subtype :
Plasma, Serum
Available Clinical Data:
Donor Blood Type, Current Medications or Treatments 1
Available Tests:
International Normalized Ratio

Sample Subtype :
Insulin
Matrix Subtype :
Serum

Sample Subtype :
Lipemia
Matrix Subtype :
Plasma, Serum
Available Clinical Data:
Date of Birth, Lipemia (laboratory evidence), Reported Age, Elevated albumin (Alb) (laboratory evidence), Date of Draw, Ethnicity, Subject is 18 years of age or older at the time of enrollment and blood draw, Alcoholic cirrhosis (clinical diagnosis and/or laboratory evidence), Date of Consent, Time of Draw, Date of Diagnosis, Country of Origin, Elevated alanine amino transferase (ALT) (laboratory evidence), City of Origin, Gender, Subject receiving treatment, Date of onset of first symptoms
Available Tests:
Triglycerides, Total Protein, Total Bilirubin, NT-Pro BNP, Abbott Anti-HCV, LDL, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, HDL, Cholesterol, ANA, IgG by IFA

Sample Subtype :
IPTH
Matrix Subtype :
Plasma, Serum
Available Tests:
TSH, iPTH

Sample Subtype :
Leishmaniasis
Matrix Subtype :
Plasma
Available Clinical Data:
Positive Leishmaniasis Biopsy?, Signs and Symptoms (Leishmaniasis), Date of onset of first symptoms, Leishmaniasis Infection Type
Available Tests:
Kalazar Detect Rapid Test for Visceral Leishmaniasis, Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative

Sample Subtype :
ThinPrep Liquid
Matrix Subtype :
ThinPrep NILM

Sample Subtype :
Low Risk HIV, LR HIV
Matrix Subtype :
Serum, Serum SST, Plasma EDTA K3

Sample Subtype :
Lyme
Matrix Subtype :
WB EDTA K3, WB PAXgene RNA, Plasma, Serum, Whole Blood, Plasma Na Citrate
Available Clinical Data:
Date of Birth, Reported Age, Date Treatment or Medication 1 Began, Visit Number, Date of Draw, Time of Centrifugation, Ethnicity, Date Treatment or Medication 3 Ended, Date Treatment or Medication 2 Ended, Subject is 18 years of age or older at the time of enrollment and blood draw, Date of Tick Bite, Date of Consent, Current Medications or Treatments 2, Other Signs and Symptoms (Tick Born), Time of Draw, Date of Diagnosis, If yes, select confirmatory lab results, Current Medications or Treatments 3, Specify Tick-Borne illness, Tick Exposure Site, Date Treatment or Medication 1 Ended, Where was the patient exposed?, Gender, Current Medications or Treatments 1, Date of onset of first symptoms, Date Treatment or Medication 3 Began, Time Frozen at -20 C or colder, Date Treatment or Medication 2 Began, Signs and Symptoms (Tick Born Disease)
Available Tests:
Lyme WB IgG (B. burdorferi), Total Protein, Total Bilirubin, Ehrlichia chaffeensis Ab, IgG by IFA, Ehrlichia chaffeensis Ab, IgM by IFA, Lyme IgG-IgM, Abbott Anti-HCV, Lyme WB IgM (B. burgdorferi), DiaSorin Lyme, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Borrelia burgdorferi Ab, Total ELISA, Babesia microti Ab IgG by IFA, Immunetics C6 B.burgdorferi Lyme, Babesia microfi Ab IgM by IFA

Sample Subtype :
Measles
Matrix Subtype :
Serum, Serum SST, Plasma EDTA K3, Human Cord Serum
Available Clinical Data:
Date of Birth, Date of Draw, Time of Centrifugation, Date and Time of Draw, Ethnicity, Date and Time of Sample Collection, Date of Consent, Time of Draw, Date of Diagnosis, Country of Origin, City of Origin, Signs and Symptoms (Measles), Gender, Site Reported Measles Test (IgM by Flocculation), Date of onset of first symptoms, Time DBS venous frozen at -20 C or colder, Time Frozen at -20 C or colder
Available Tests:
BIO-RAD BIOPLEX Measles, LIAISON Mumps IgG, Measles (Rubeola) Antibody, IgM, LIAISON Measles IgG, LIAISON Rubella IgG, Measles IgG

Sample Subtype :
Multiple Myeloma
Matrix Subtype :
Plasma, Serum

Sample Subtype :
Multiple Sclerosis
Matrix Subtype :
Plasma, Serum

Sample Subtype :
Mumps
Matrix Subtype :
Serum, Serum SST
Available Tests:
Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Mumps IgG

Sample Subtype :
Mycoplasma Pneumonia
Matrix Subtype :
Plasma

Sample Subtype :
NASH
Matrix Subtype :
Plasma EDTA K2, Serum SST, Plasma EDTA K3
Available Clinical Data:
Date of Birth, Ethnicity (hispanic specific), Reported Age, Date of Draw, Albumin, Ethnicity, Prothrombin Date Performed, Bilirubin, Subject is 18 years of age or older at the time of enrollment and blood draw, Albumin Test Range, Prothrombin Time, Date of Consent, Abbott Architect Anti HCV Result, Bilirubin test range, Time of Draw, Date of Fibrosis Score, Albumin Test Date, Date Bilirubin Test Performed, Date sample frozen at -20 C or colder, City of Origin, Is the most recent liver biopsy result available?, If yes, stage of biopsy (Biopsy performed), If yes, date performed (Biopsy performed), Gender, Fibrosis Score, State of Origin, Time Frozen at -20 C or colder, Sample Storage Temperature
Available Tests:
AST, ALT, Architect SARS-CoV-2 IgG

Sample Subtype :
Adult Male, Flu Vaccine, Challenged HIV Neg., HAV Vaccination, Normal Healthy
Matrix Subtype :
Saliva, WB EDTA K3, Plasma, Serum, WB EDTA K2, Plasma EDTA K2, Plasma CPDA-1, Whole Blood, WB ACD-A, Saline OPS, WB Na Citrate, Serum SST, Buccal Swab, Oropharyngeal Swab, Plasma CPD, Urine, Plasma Na Citrate, Plasma Lithium Heparin, Plasma EDTA K3
Available Clinical Data:
Examination Procedure (Oncology), Date of Birth, Reported Age, Symptomology at the Time of Diagnosis, Date of Draw, Date and Time of Draw, Ethnicity, Vaccine Manufacturer, Blood Type, Test Date (site reported results), Vaccine Name, Does the subject smoke?, Date of Consent, Pre-Existing Medical Conditions, Time of Draw, In the 14 days prior to illness onset, did the subject have any of the following exposures?, Examination Procedure Findings, Country of Origin, City of Origin, Did the subject receive Mechanical Ventilation (MV) / Intubation?, Signs and Symptoms (Respiratory Infection), Diagnosis (Oncology), Gender, Was the subject hospitalized?, Buccal Swab Collection Site, If pregnant, which trimester?, Date of hospitalization, Fever Temperature (F), Date of Procedure, Date of Blood Collection, Concomitant Medications (if reported), Is the subject a healthcare worker?, Date of Vaccine Administration, Date of onset of first symptoms, COVID-19 PCR Test Manufacturer, Time Frozen at -20 C or colder, Date of discharge from hospital?, Site reported laboratory results
Available Tests:
Liaison HSV-2 IgG, COVID-19 IgG, Qualitative by CIA, DiaSorin Zika IgM, Influenza A Virus Antibody IgM, EuroImmun COVID-19 IgG, Aptima Zika Virus Assay - Urine, Influenza B Virus Antibody IgM, Abbott Anti-HCV, Abbott HB Core, BioGX SARS-CoV-2, Liaison CMV IgG, EDI COVID-19 IgM, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, EuroImmun COVID-19 IgA, Abbott Syphilis TP, Influenza A Virus Antibody IgG, HIV 1/2 ab, Influenza B Virus Antibody IgG, Toxoplasma gondii Antibody, IgG, LIAISON Rubella IgG, Liaison HSV-1 IgG, EDI COVID-19 IgG, Architect SARS-CoV-2 IgG, Perkin Elmer SARS-CoV-2, Syphilis, Abbott Anti-HBs (AUSAB)

Sample Subtype :
NT-proBNP
Matrix Subtype :
Serum
Available Clinical Data:
Reported Age, Date of Draw, Gender
Available Tests:
NT-proBNP

Sample Subtype :
Immunosuppressant
Matrix Subtype :
WB EDTA K3, Plasma EDTA K3
Available Clinical Data:
Reported Age, Date of Transplant, Date of Draw, Time of Centrifugation, Ethnicity, Type of Transplant, Date of Consent, Time of Draw, Country of Origin, Date of Immunosuppressant Drug Administration / Treatment Start, Subject has undergone an organ transplant procedure., Gender, Subject is currently taking at least one of the following immunosuppressant drugs: Cyclosporine, Sirolimus, Tacrolimus, or Everolimus., Time Frozen at -20 C or colder, Immunosuppressant Drug
Available Tests:
Tacrolimus by Tandem Mass Spectrometry, Cyclosporine A by Tandem Mass Spectrometry, Sirolimus by Tandem Mass Spectrometry

Sample Subtype :
Osteoarthritis
Matrix Subtype :
Plasma, Serum

Sample Subtype :
PBC
Matrix Subtype :
Plasma EDTA K3
Available Clinical Data:
Date of Birth, Reported Age, Fibrosis Score (Choose One), Date of Draw, Ethnicity, Periportal Necroinflammatory Score (Choose one), Subject is 18 years of age or older at the time of enrollment and blood draw, Date of Consent, Abbott Architect Anti HCV Result, Time of Draw, Portal Inflammation Score (Choose one), Date sample frozen at -20 C or colder, City of Origin, Is the most recent liver biopsy result available?, Gender, Liver Biopsy Date Tested:, Scoring System: Focal (Spotty) Lobular Necrosis and Hepatocellular Apoptosis Score (Choose one), Current Medications or Treatments 1, Scoring System: Bridging and Confluent Necrosis Score (Choose One), Sample Storage Temperature
Available Tests:
AST, ALT

Sample Subtype :
Newborn, Pediatric, Tanner Stage 4, HIV Pediatric, Tanner Stage 1, Healthy Pediatric
Matrix Subtype :
Plasma, Serum, Plasma EDTA K2, Serum SST, Plasma EDTA K3
Available Clinical Data:
Date of Birth, Date of Draw, Time of Centrifugation, Ethnicity, Date of Consent, Current Medications or Treatments 2, Date of Diagnosis, Time of Draw, Current Medications or Treatments 3, Country of Origin, City of Origin, Gender, Current Medications or Treatments 1
Available Tests:
Bio-Rad Geenius HIV 1/2 Supplemental Assay, Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative

Sample Subtype :
BHCG, Pregnancy, Healthy Pregnancy, HIV Pregnancy
Matrix Subtype :
Plasma, Serum, Plasma EDTA K2, Serum SST, Amniotic Fluid, Urine, Plasma EDTA K3
Available Clinical Data:
Date of Birth, Weeks of Pregnancy, Reported Age, Date of Draw, Time of Centrifugation, Ethnicity, Does the patient have diagnostic testing?, Subject is 18 years of age or older at the time of enrollment and blood draw, Months Pregnant?, Date of Consent, Time of Draw, Date of Diagnosis, Country of Origin, City of Origin, Suspected Tropical Disease, Gender, If pregnant, which trimester?, Gestational Age (weeks), Tropical Disease Signs and Symptoms, Date of onset of first symptoms, Patient Has Documentation For Yellow Fever Vaccination, Time Frozen at -20 C or colder
Available Tests:
Ferritin, Bordetella pertussis Antibody, IgG by ELISA, Total Protein, TSH, Liaision SARS-CoV-2 Ab, Total Bilirubin, Influenza A Virus Antibody IgM, Mycoplasma Pneumoniae Antibody IgM, Aptima Zika Virus Assay - Urine, Beta-hCG, Serum Qualitative, Influenza B Virus Antibody IgM, Insulin-Like Growth Factor (IGF-1), FSH, Abbott Anti-HCV, Mycoplasma Pneumoniae Antibody IgG, Liaison CMV IgG, Aptima Zika Virus Assay - Serum, Human Chorionic Gonadotropin (hCG), Luteinizing Hormone (LH), Abbott HIV Ag/AB Combo, LIAISON Mumps IgG, AST, Free T3, Abbott HBsAg Qualitative, Alkaline Phosphatase, ALT, Abbott Syphilis TP, Influenza A Virus Antibody IgG, PSA (Prostatic Specific Antigen), Influenza B Virus Antibody IgG, Direct Bilirubin, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Varicella-Zoster Virus Antibody, IgG, Beta-hCG, Serum Quantitative, Progesterone II Gen, hGH, LIAISON Measles IgG, Toxoplasma gondii Antibody, IgG, Creatinine, LIAISON Rubella IgG, Testosterone, Prolactin, Free T4, Free PSA (Prostatic Specific Antigen), Architect SARS-CoV-2 IgG, Haemophilus influenzae b Antibody, IgG

Sample Subtype :
Procalcitonin
Matrix Subtype :
Serum

Sample Subtype :
PSA
Matrix Subtype :
Serum
Available Tests:
PSA (Prostatic Specific Antigen), Cryptococcus Ag

Sample Subtype :
Psoriatic Arthritis
Matrix Subtype :
Serum

Sample Subtype :
SARS-CoV-2
Matrix Subtype :
Liquid Amies, Multitrans medium, Plasma, Serum, VTM, Saline, E-Swab, UTM, Aptima Swabs
Available Clinical Data:
Birth Year, Date of Draw, Gender
Available Tests:
Hologic Panther SARS-CoV-2, LIAISON SARS-CoV-2, Liaision SARS-CoV-2 Ab, GeneXpert SARS-CoV-2, Hologic Panther Fusion SARS-CoV-2, BioGX SARS-CoV-2, ABBOTT M2000 SARS-CoV-2, Architect SARS-CoV-2 IgG, Perkin Elmer SARS-CoV-2

Sample Subtype :
RSV
Matrix Subtype :
Nasopharyngeal swabs

Sample Subtype :
RF
Matrix Subtype :
Plasma, Serum, Plasma CPD, Plasma EDTA K3
Available Tests:
Triglycerides, Total Protein, Total Bilirubin, Chloride (Cl), Abbott Anti-HCV, Potassium (K), Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Albumin, Cholesterol, Direct Bilirubin, Phosphorus, Calcium, Sodium (NA)

Sample Subtype :
RA
Matrix Subtype :
Plasma, Serum, Plasma EDTA K3
Available Tests:
Rheumatoid Factor, Immunoglobulin G, ImmunoConcepts Hep-2000, NT-Pro BNP, Abbott Anti-HCV, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Lex-RALatex, Abbott HIV Ag/AB Combo, AST, Abbott HBsAg Qualitative, ALT, Abbott Syphilis TP, Free Hemoglobin Serum, RA, ANA, IgG by IFA, Cyclic Citrullinated Peptide (CCP) Antibody, IgG

Sample Subtype :
Rosacea
Matrix Subtype :
Punch Biopsy Skin
Available Clinical Data:
Microscopic Description, Reported Age, Gross Description, Ethnicity, Sample Diameter (mm), Sample Location, Diagnosis (Oncology), Gender, Date of Procurement

Sample Subtype :
RPR
Matrix Subtype :
Serum

Sample Subtype :
Rubella, Rubella IgG, Rubella IgM
Matrix Subtype :
Plasma, Serum, Plasma EDTA K3
Available Tests:
Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Rubella IgG

Sample Subtype :
Sickle Cell
Matrix Subtype :
Plasma

Sample Subtype :
SLE
Matrix Subtype :
Plasma, Serum, Plasma EDTA K3
Available Clinical Data:
Date of Birth, Reported Age, Date of Draw, Ethnicity, Rheumatology Condition, Stage of ATL, Time of Draw, Date of Diagnosis, Treatment History, Country of Origin, City of Origin, Gender, State of Origin, Medication Start Date
Available Tests:
Genetic Systems HBsAg EIA 3.0, Rheumatoid Factor, Immunoglobulin G, ImmunoConcepts Hep-2000, NT-Pro BNP, Abbott Anti-HCV, Anti-Nuclear Antibodies (ANA), IgG by ELISA, Abbott HIV Ag/AB Combo, AST, Abbott HBsAg Qualitative, ALT, Abbott Syphilis TP, Free Hemoglobin Serum, ANA, IgG by IFA, Cyclic Citrullinated Peptide (CCP) Antibody, IgG

Sample Subtype :
Sodium
Matrix Subtype :
Serum

Sample Subtype :
Neisseria Gonorrhoeae
Matrix Subtype :
Aptima Vaginal Swab, Urine
Available Tests:
Neisseria gonorrhoeae

Sample Subtype :
Group B Streptococci, Group G Streptococci  , Group C Streptococci
Matrix Subtype :
Throat Swab

Sample Subtype :
Signs/Symptoms Hep.
Matrix Subtype :
Plasma, Serum SST, Plasma EDTA K3
Available Clinical Data:
Date of Birth, One or more of the following within 4 weeks of enrollment:, Date of Draw, Time of Centrifugation, Ethnicity, Subject is 18 years of age or older at the time of enrollment and blood draw, One or more of the following:, Date of Consent, Time of Draw, Country of Origin, City of Origin, Gender, Two or more of the following within 4 weeks of enrollment:, Date of onset of first symptoms
Available Tests:
Architect Anti-HAV IgG, Architect Anti-HAV IgM

Sample Subtype :
Syphilis Lat. T, Syphilis Prim. T, Syphilis
Matrix Subtype :
Plasma, Serum, Serum SST, Plasma EDTA K3
Available Clinical Data:
Date of Birth, Date of Draw, Time of Centrifugation, Ethnicity, Syphilis Treatment Status, Date of Consent, Date of Diagnosis, Time of Draw, Site Reported Syphilis RPR Result (flocculation), Country of Origin, City of Origin, Gender, Syphilis Stage of Infection, Time Frozen at -20 C or colder
Available Tests:
Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Abbott Syphilis TP, V.D.R.L Test, Syphilis RPR

Sample Subtype :
TDA
Matrix Subtype :
Saliva, WB EDTA K3, WB PAXgene RNA, Plasma, Serum, WB Plasma, Whole Blood, Urine, Plasma EDTA K3
Available Clinical Data:
Date of Draw, If pregnant, which trimester?
Available Tests:
Chikungunya Differenciation, DiaSorin Zika IgM, Dengue Differenciation, Aptima Zika Virus Assay - Urine, InBios WNV IgM, EuroImmun Anti-Chikungunya Virus IgG, InBios Zika IgM Capture, DiaPro Zika Virus IgG, Aptima Zika Virus Assay - Serum, InBios Anti-Dengue IgM, InBios Anti-Dengue IgG, EuroImmun Anti-Chikungunya Virus IgM, ZIKV Detect 2.0 IgM Capture ELISA, LIAISON Rubella IgG

Sample Subtype :
Zika, Acute Dengue, Toxoplasmosis, Dengue, Acute Chikungunya, Chikungunya PL, ZikaPL, Leishmaniasis, TDS, TDSPL, Malaria, CZPL, Leptospirosis, Chikungunya
Matrix Subtype :
Saliva, WB EDTA K3, WB PAXgene RNA, Plasma, Serum, WB EDTA K2, Plasma CPDA-1, WB Plasma, Whole Blood, Plasma ACD, Serum SST, Amniotic Fluid, Urine, Plasma Na Citrate, Plasma EDTA K3, Human Cord Serum, Umbilical Cord Plasma
Available Clinical Data:
Date of Birth, Site Reported Dengue IgM, Date of Draw, Time of Centrifugation, Ethnicity, Does the patient have diagnostic testing?, Subject is 18 years of age or older at the time of enrollment and blood draw, Date of Consent, Tropical Disease Other Signs and Symptoms, Pregnant?, Time of Draw, Country of Origin, City of Origin, Suspected Tropical Disease, Gender, Infection Status, If pregnant, which trimester?, Suspected Tropical Disease:, Subject has high fever and at least two tropical disease signs and symptoms, Tropical Disease Signs and Symptoms, Date of onset of first symptoms, Patient Has Documentation For Yellow Fever Vaccination, Time Frozen at -20 C or colder
Available Tests:
BinaxNOW Malaria, Trypanosoma cruzi, IgG, Bordetella pertussis Antibody, IgG by ELISA, C. psittaci IgG, EuroImmun Anti-Dengue Virus IgM, Malaria Detection and Speciation, Qualitative by RT PCR, Chikungunya Differenciation, Dengue Virus 1-4 Subtype by PCR, C. pneumoniae IgG, DiaSorin Zika IgM, Influenza A Virus Antibody IgM, Mycoplasma Pneumoniae Antibody IgM, Dengue Differenciation, Aptima Zika Virus Assay - Urine, DiaPro Anti-Dengue Virus IgM, Adenovirus Antibody, Serum, C. psittaci IgM, Influenza B Virus Antibody IgM, InBios Dengue NS-1, HAV RT-PCR, UltraQual 1000 2x, InBios WNV IgM, Abbott Anti-HCV, C. trachomatis IgG, C. trachomatis IgM, EuroImmun Anti-Chikungunya Virus IgG, InBios Zika IgM Capture, Mycoplasma Pneumoniae Antibody IgG, DiaPro Zika Virus IgG, Aptima Zika Virus Assay - Serum, InBios Anti-Dengue IgM, InBios Anti-Dengue IgG, DiaPro Anti-Chikungunya IgG, Abbott HIV Ag/AB Combo, EuroImmun Anti-Chikungunya Virus IgM, Abbott HBsAg Qualitative, InBios Chikungunya IgG, InBios WNV IgG, C. pneumoniae IgM Titer, EuroImmun Anti-Dengue Virus IgG, DiaPro Zika Virus IgM, InBios Chikungunya IgM, Abbott Syphilis TP, Influenza A Virus Antibody IgG, Influenza B Virus Antibody IgG, DiaPro Anti-Dengue Virus IgG, ZIKV Detect 2.0 IgM Capture ELISA, EuroImmun Anti-Zika Virus IgG, Trypanosoma cruzi, IgM, Leptospira Antibody, IgM by Dot Blot, EuroImmun Anti-Zika Virus IgM, Zika MAC-ELISA, DiaPro Anti-Chikungunya IgM, EuroImmun Anti-WNV IgG, Aptima Zika Virus Assay - Plasma, Haemophilus influenzae b Antibody, IgG, Chikungunya by PCR, COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0, WNV-PCR: (Roche WNV-PCR), Syphilis

Sample Subtype :
TPO
Matrix Subtype :
Serum
Available Tests:
Thyroglobulin, Thyroid Peroxidase

Sample Subtype :
Chronic Lyme Disease, Lyme Disease, Tick-Borne
Matrix Subtype :
WB EDTA K3, WB PAXgene RNA, Plasma, Serum, Whole Blood, Serum SST, Plasma EDTA K3
Available Clinical Data:
Date of Birth, Lipemia (laboratory evidence), Reported Age, Date Treatment or Medication 1 Began, Visit Number, Date of Draw, Time of Centrifugation, Date and Time of Draw, Ethnicity, Date Treatment or Medication 3 Ended, Date Treatment or Medication 2 Ended, Subject is 18 years of age or older at the time of enrollment and blood draw, Date of Tick Bite, Date of Consent, Current Medications or Treatments 2, Other Signs and Symptoms (Tick Born), Pregnant?, Date of Diagnosis, Time of Draw, If yes, select confirmatory lab results, Current Medications or Treatments 3, Specify Tick-Borne illness, Tick Exposure Site, Country of Origin, Confirmatory lab results (Tick Born), Date Treatment or Medication 1 Ended, Where was the patient exposed?, Gender, Current Medications or Treatments 1, Date of onset of first symptoms, Date Treatment or Medication 3 Began, Date Treatment or Medication 2 Began, Time Frozen at -20 C or colder, Signs and Symptoms (Tick Born Disease)
Available Tests:
Lyme WB IgG (B. burdorferi), Ehrlichia chaffeensis Ab, IgG by IFA, Ehrlichia chaffeensis Ab, IgM by IFA, Lyme WB IgM (B. burgdorferi), DiaSorin Lyme, Anaplasma phagocytophilum (HGA) Ab, IgM, Borrelia burgdorferi Ab, Total ELISA, Babesia microti Ab IgG by IFA, Lyme PCR (Borrelia species), Immunetics C6 B.burgdorferi Lyme, Babesia microfi Ab IgM by IFA

Sample Subtype :
TORCH Negative
Matrix Subtype :
Plasma, Plasma Na Citrate

Sample Subtype :
Total Bilirubin
Matrix Subtype :
Serum

Sample Subtype :
Total Protein
Matrix Subtype :
Serum
Available Tests:
Total Protein

Sample Subtype :
BUP, 6AM
Matrix Subtype :
Urine
Available Tests:
Buprenorphine - Urine, 6-Acetylmorphine

Sample Subtype :
Toxicology Specimen
Matrix Subtype :
Urine

Sample Subtype :
Toxo IgG, Toxo IgM
Matrix Subtype :
Plasma, Serum, Plasma EDTA K3
Available Clinical Data:
Toxoplasma Gondii IgM (Site Reported CLIA), Infection Status, Signs and Symptoms (Toxoplasmosis)
Available Tests:
Toxoplasma gondii Ab, IgM, Toxoplasma gondii Antibody, IgG

Sample Subtype :
Triglycerides
Matrix Subtype :
Serum
Available Tests:
Triglycerides

Sample Subtype :
Ulcerative Colitis
Matrix Subtype :
Serum SST, Plasma EDTA K3
Available Clinical Data:
Date of FCP Result, If on medications, for how long? (days), Date of Birth, Ethnicity (hispanic specific), Reported Age, Date of Draw, Ethnicity, Prior Biologic Treatment History, Date of CRP result, Subject is 18 years of age or older at the time of enrollment and blood draw, What medication(s) is the subject currently taking?, Most recent Fecal Calprotectin (FCP) result, Date of Consent, Time of Draw, Date of Diagnosis, Gastroenterology Condition, Disease Status at time of sample collection, Clinical Symptom Score (CD: CDAI), Country of Origin, Date sample frozen at -20 C or colder, City of Origin, Most recent C-reactive protein (CRP) result, Gender, Time Frozen at -20 C or colder, Is the subject currently on medications?

Sample Subtype :
UTI
Matrix Subtype :
Aptima Vaginal Swab, Urine
Available Clinical Data:
Identity of Bacterial Infection, UTI Bacteria Concentration (CFU) (Site Reported)
Available Tests:
Neisseria gonorrhoeae, Chlamydia trachomatis

Sample Subtype :
VARPL
Matrix Subtype :
Plasma, Plasma Na Citrate
Available Tests:
Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative

Sample Subtype :
HCV/HIV, HBV/HCV, HBV/HCV/HIV, HBV/HIV
Matrix Subtype :
Plasma
Available Clinical Data:
Sample Hemolysis Level (Qualtex Color Comparator)
Available Tests:
Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative

Sample Subtype :
VZV, VZVPL
Matrix Subtype :
Plasma, Serum, Plasma Na Citrate, Plasma EDTA K3
Available Clinical Data:
Date of Birth, Anatomical location(s) of fluid filled blisters., VZV IgM Test Result (Site Reported), Date of onset of first symptoms, Signs and Symptoms (Varicella Zoster)
Available Tests:
VZV IgG, Varicella-Zoster Virus Antibody, IgM, Abbott Anti-HCV, Abbott HIV Ag/AB Combo, Abbott HBsAg Qualitative, Epstein-Barr Virus Ab to Viral Capsid Antigen, IgG, Varicella-Zoster Virus Antibody, IgG, LIAISON Measles IgG, LIAISON Rubella IgG

Sample Subtype :
WNV
Matrix Subtype :
Plasma, Serum, Plasma CPD, Plasma EDTA K3
Available Tests:
InBios WNV IgM, InBios WNV IgG, WNV-PCR: (Roche WNV-PCR)
Can't find what you're looking for? Let us know
check mark black
Unlock the potential of your science with us
Contact Us